{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PIWORLD Investor Podcasts","title":"Amryt Pharma (AMYT) – Investor presentation at ShareSoc September 2018","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/c2c0ed98\"></iframe>","width":"100%","height":180,"duration":2234,"description":"the full video can be seen at: https://www.piworld.co.uk/2018/09/25/amryt-pharma-amyt-investor-presentation-at-sharesoc-september-2018/\nPresentation by Amryt Pharma CCO, David Allmond.\nAmryt Pharma plc is a commercial-stage specialty pharmaceutical company focused on developing and delivering treatments for patients with rare and orphan diseases. The Company is building a diversified portfolio of proprietary drugs to help address some of rare and debilitating illnesses.\nThe team – 00:27The vision - 02:12Amryt overview – 04:04Commercial & development pipeline - 06:00Strategy – 3 pillars of growth - 07:43Lojuxta - 10:02Epidermolysis Bullosa (EB) AP101 - 12:20AP103 – building an EB franchise - Gene Therapy Platform - 18:26In-License Opportunities - 21:07Financials - 22:16Investment case - 22:55Q&A - 24:18","thumbnail_url":"https://img.transistorcdn.com/oB5fNE4aIAia_YyTCKvE1PzrZQaD1Fjo_P7m7T9Aw_Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTJi/ODBiMzBmOGFhZWJi/MWEzYThkMzAyNmZm/MTdjZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}